Aug. 13, 2025 — BioCardia, Inc., a provider of cellular and cell-derived therapeutics for treating cardiovascular and ...
Aug. 14, 2025 — Philips has announced a plan for new investments of more than $150 million in U.S. manufacturing and ...
August 14, 2025 — PaceMate has officially completed a year-long project, resulting in two new exclusive abilities. The ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Aug. 7, 2025 — Gentuity LLC, a medical technology company specializing in next-generation intravascular imaging devices ...
Aug. 13, 2025 — Registration is now open for the RSNA 111th Scientific Assembly and Annual Meeting, the world’s leading ...
Aug. 13, 2025 — A recent study published in the Journal of the Society for Cardiovascular Angiography & Interventions ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Aug. 11, 2025 — Elucid announced that United Healthcare has updated its cardiac imaging guidelines to align with recent ...
Aug. 07, 2025 —- New research by European cybersecurity company Modat revealed more than 1.2 million internet-connected ...
Aug. 4, 2025 — Living with cardiovascular disease often takes a serious emotional toll — and with stress known to worsen ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...
Aug. 5 — HeartBeam, a cardiac technology company, has secured two new U.S. patents that significantly enhance its ...
Aug. 4, 2025 — Corcym announced that its Perceval Plus sutureless aortic heart valve was used in a first-ever robotic ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Aug. 4, 2025 — A new peer-reviewed study in the American Journal of Preventive Cardiology shows Hello Heart’s digital ...
Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...
July 30. 2025 — Cardiosense, a medical AI company, recently announced that the U.S. Food and Drug Administration (FDA) ...
August 15, 2025
